Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Pathology & Lab Medicine

NewLink Genetics and Roche have teamed up to develop NewLink’s cancer immunothereapy in a $1 billion deal, Reuters reports. The NewLink inhibitor, NLG919, works to disrupt the process through which tumors elude a patient’s immune system....
An experimental T-Cell therapy which genetically programs a patient’s cells to fight disease is showing promise in bringing remission to leukemia patients, The New York Times reports. According to a study published in The New England Journal of...

Stem Cells & Ophthalmology

Stem Cells for Improved Vision

According to The New York Times, a new development in stem cell research emerged after an extensive trial on patients with eye diseases. A study published in The Lancet looked at 18 patients with eye diseases, following their progress for a median of 22...